Álvaro
López Janeiro
Colaborador Clínico
University of North Carolina at Chapel Hill
Chapel Hill, Estados UnidosPublications en collaboration avec des chercheurs de University of North Carolina at Chapel Hill (1)
2023
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378